Treatment of Clostridium difficile colitis.
D000818:Animals; D001414:Bacitracin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003013:Clostridium / Q000187:drug effects*; D003015:Clostridium Infections / Q000188:drug therapy* / Q000191:economics; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy* / Q000191:economics; D005672:Fusidic Acid / Q000627:therapeutic use; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D011897:Random Allocation; D014640:Vancomycin / Q000009:adverse effects / Q000627:therapeutic use
D001414:Bacitracin; D008795:Metronidazole; D005672:Fusidic Acid; D014640:Vancomycin